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Abstract
Depression is a pervasive mental health disorder worldwide. Although being diagnosed
with chronic illness exacerbates susceptibility to depression, detection and subsequent
treatment of comorbid depression in primary care settings remain suboptimal because
patients with chronic medical disorders are not commonly screened for depression. There
is a need to initiate proactive measures by implementing routine screening in primary
care settings. The plan-do-study-act (PDSA) model guided an intervention to establish a
depression screening practice. This study aimed to determine if the implementation of
evidence-based screening for depression using the Patient Health Questionnaire-9 (PHQ9) tool could increase diagnosis of comorbid depression among patients suffering from
chronic diseases. Convenience sampling served as the method for selecting healthcare
records that met the predetermined criteria. Two hundred established patients over 18
years of age were screened for depression at a primary care clinic in Maryland within a
10-week period following Diagnostic and Statistical Manual of Mental Disorders (DSMIV) criteria. Study participants included 84 (42%) males and 116 (58%) females. Of
these, 84 (42%) had minimal depression, 57 (29%) had mild depression, 23 (12%) had
moderate depression, 24 (12%) had moderate-severe depression, and 12 (6%) had severe
depression. The baseline report from the clinic revealed 0% depression screening
practices yet the post-project chart review revealed a surprisingly high rate of depression
diagnosis in 34 (17%) of 200 patients suffering from chronic illnesses. Identification of a
reliable tool that would be used to screen depression among patients with chronic
diseases at primary care clinics to mitigate the deleterious effects of depression and
promote the well-being and health of patients and their families is important.
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Section 1: Introduction
People who live with chronic illnesses make many adjustments to their lives
because chronic diseases can limit their independence, and mobility. They become less
active and more dependent on others for activities of daily living (Fegg, Kraus, Graw, &
Bausewein, 2015). Chronic diseases that are associated with depression include cancer,
stroke, heart problems, diabetes, and osteoporosis (Fegg et al., 2015). Consequently, it is
crucial that chronic disease management is improved by integrating screening of
depression.
The World Health Organization (WHO) claimed that mental disorders including
depression are global health problems (Thapar et al., 2012). The WHO further predicted
that by 2030, depression would be a causative factor in more years of life lost due to
disability than any other type of health condition. Early detection of depression is critical
because of the heavy burden of suffering that accompanies it. Sometimes, depression
ends in suicide. There is an emerging bidirectional relationship between depression and
chronic illness. Comorbid depression does lead to functional impairment, and poor
outcomes (Thapar et al., 2012). Comorbid depression can invoke feelings of hopelessness
and helplessness, which can sap the motivation of patients to care for themselves.
Depressed patients are less likely to adhere to treatment regimens and often end
up with incomplete recovery (Culpepper, Muskin, & Stahl, 2015). As such, an evidencebased depression screening tool, the Patient Health Questionnaire-9 (PHQ-9), was
introduced and served as an integral part of the initial encounter with patients suffering
from chronic illness at a designated primary care clinic. The significant prevalence of
depression in patients who have chronic diseases suggested that this is a disorder with the
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potential to impact the medical outcomes of these patients negatively (Culpepper et al.,
2015). According to findings of research by Kang et al. (2015), the depression rate
among patients suffering from chronic diseases is significantly higher than that of their
counterparts who do not suffer from such diseases. The use of an evidence-based
screening tool with excellent sensitivity such as the PHQ-9 represents a significant step
toward identifying patients with chronic diseases who are suffering from depression.
Currently, depression is the second leading cause of disability, adjusted in life years,
among individuals aged between 15 and 44 years (Voinov, Richie, & Bailey, 2013).
Depression shortens life expectancy by 25 to 30 years (WHO, 2014). It is evident that
this health condition can be identified through screening to reduce the risk of disabilities
that accompanies it. The condition can be identified and treated in primary health care
settings using antidepressants and psychotherapy regimens that have been reported to be
effective 80% of the time (WHO, 2012).
This project highlights the importance of depression screening tools in primary
care and the need to implement a routine screening for depression among patients with
chronic illnesses. The goal is to reduce the problem of undiagnosed depression in primary
care settings. This study not only encourages screening and detection of depression as a
comorbid condition among individuals with chronic diseases but also encourages (PCPs)
to discuss the results of such screenings with identified participants and proceed with the
next intervention to improve patient outcomes; while increasing the number of patients
receiving treatment in primary care settings.
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Problem Statement
Depression is a widespread mental health ailment across the world (WHO, 2014).
It is also a leading causative factor for disability. This quality improvement project was
conducted at a suburban primary care clinic located in the eastern region of Maryland.
The average resident at this location was more at risk of suffering from chronic diseases
compared to the national average because of disparities in access to health care services
and preventive resources (National Institute of Mental Health, 2017). Research indicates
that there is a 15.6% risk of depression among individuals with chronic conditions such
as asthma, chronic obstructive pulmonary disease (COPD), arthritis, heart disease, and
osteoporosis (Bhattacharya, Shen, & Sambamoorthi, 2014). Maryland is in the second
unhealthiest region in the United States (Maryland Department of Health, n.d.). The
adjusted rate of cardiovascular disease in Maryland by race is 50.3 per 100,000
populations among African American men, 45.2 among African American women, 34.8
among Caucasian women, and 33.5 among Caucasian men (Maryland Department of
Health, n.d.). The adjusted rate for cancer for the entire state among all races is 449.8 per
100,000 populations; among males of all races, it is 507.5 (Community Care of North
Carolina, 2015). The adjusted rate for colorectal cancer for the whole state is 14.9; among
men, it is 21.1, and among women, it is 12.5 (Community Care of North Carolina, 2015).
The National Institute of Mental Health (2017) has endorsed integrated care for
mental health into primary care settings because individuals with mental disorders have
higher rates of chronic physical illnesses. People are more likely to visit a primary care
setting than a mental health system. If mental disorders are routinely screened for in
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primary care settings, PCPs can provide care for conditions such as depression and
anxiety.
Research has confirmed the claims of the U.S. Preventive Services Task Force
(USPSTF) that screening improves the accuracy of detection of depression in primary
care settings (Siu, 2016). The USPSTF further reported that nine clinical trials were
conducted that addressed screening in adults, with results adequate to establish the
benefits of the treatment of depression (e.g., initiating antidepressants and
psychotherapy). Screening for depression was found to significantly improve overall
health outcomes (Culpepper et al., 2015).
The quality improvement project holds significance for nursing practice. Due to
the increase of health care coverage through the affordable health care program, many
patients view primary care clinics as more convenient and reasonable than going to the
emergency room (U.S. Preventive Services Task Force, 2014). Thus, introducing routine
depression screening practice in this primary care setting was ideal for this population.
Patients diagnosed with chronic diseases such as cancer, hypertension, stroke, arthritis,
diabetes, heart disease, and chronic lung disease are more likely to be at risk for
depression than their counterparts (Wu, 2013).
With the introduction of an evidence-based depression screening tool at the
designated primary care practice, the detection of depression risks in this population
group was increased. The proposed routine screening practice served as an integral part
of an initial encounter for patients suffering from chronic illnesses in the primary care
setting. This doctoral project was necessary because research findings indicated that the
number of American people receiving mental health care from PCPs was increasing
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(Olsen, 2014). This doctoral project endeavored to demonstrate that there is a need to
introduce screening for depression among patients with chronic diseases in primary care
settings where depression screening practices are lacking.
Purpose Statement and Project Objectives
The goal of this quality improvement project was to determine if the
implementation of an evidence-based depression screening tool could improve early
identification and detection of comorbid depression among patients suffering from
chronic diseases at a primary care clinic located in Maryland. The project applied the
PDSA model as the framework to establish a routine depression screening practice in the
clinic.
The project objective was to close an existing gap at the host primary care clinic
in Maryland. Research showed that two-thirds of all adults seen in primary care remain
undiagnosed with depression (Pence, O’Donnell, & Gaynes, 2013). This project fostered
early detection of comorbid depression among patients with chronic diseases following
implementation of routine screening for depression in this primary care setting. The
project enhanced the roles played by nurses as leaders to bring forward screening projects
in a primary care setting.
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Section 2: Background and Context
Practice Knowledge Gap
This quality improvement project was conducted at a suburban primary care clinic
located in the eastern region of Maryland. The clinic had primary care health personnel
including a physician, a nurse practitioner, a physician assistant, a registered nurse, and
three certified medical assistants. This clinic was known to offer high-quality health care
services with respect, and compassion to patients and their families. The practice had
been in existence for over 10 years. The clinic served its entire community, managing
patients with a broad range of acute and chronic diseases. The clinic had no routine
depression screening practices in place.
Despite the PCPs’ expertise in managing an array of health conditions at the clinic
site, their patients were not getting screened for depressive symptoms. Evidence
supporting this discovery came from the clinic’s data baseline report that revealed 0% of
depression screening practices and the absence of depression screening documentation in
electronic patient charts. It was essential to implement a reliable tool to screen depression
in patients with chronic diseases at this primary care clinic. The patient population was
considered vulnerable due to low educational status, financial problems, and lack of
health insurance.
Research findings continue to reveal higher depression risks in individuals
suffering from renal disease, heart disease, and chronic arthritic disease (Chiang, Livneh,
Yen, Li, & Tsai, 2013). Even among ambulatory patients who use primary care services
for health maintenance for chronic disease management, research has indicated that there
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is a significantly high rate of depression that has not been diagnosed, recognized, or
treated appropriately (Chiang et al., 2013).
Significance and Relevance to Practice
The primary care clinic’s health personnel (a physician, a nurse practitioner, a
physician assistant, a registered nurse, and three medical assistants) were involved in the
screening program. Because depression is an insidious disease that can afflict anyone,
participants included adults aged 18 and older in the state of Maryland. Routine screening
can improve early detection, and accurate identification of individuals suffering from
depression, which can reduce potential morbidity (Rankin et al., 2015). Screening can
impact clinicians by helping them to identify risks and make appropriate diagnoses to
initiate treatment or refer patients to proper resources, and thus improve the quality of
patient care, and health outcomes in their practices.
Project Question
The project question used to guide data collection, data analysis, result
examination, and outcomes was the following: In the State of Maryland, at a designated
primary care clinic site, does the implementation of evidence-based screening for
depression, using a PHQ-9 tool within the context of the PDSA Cycle, increase diagnosis
of depression?
Evidence-Based Significance of the Project
The depression screening project used the PHQ-9 as the instrument to screen
participants for depressive symptoms. The PHQ-9 is a multipurpose instrument that can
be used in practice to screen and diagnose depression. It has a depression module scoring
each of the nine criteria from the fourth edition of the Diagnostic and Statistical Manual
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of Mental Disorders (DSM-IV), such as 0 -not at all to 3 -nearly every day; (Maurer,
2012). The PHQ-9 can be used to make diagnoses of depression in at-risk population
groups. A score > 10 on the PHQ-9 is considered a positive screen for depression. The
instrument has 61% sensitivity and 94% specificity in adults (Maurer, 2012). It was
found to have good internal consistency and to be reliable and valid in prior research
(Arrieta et al., 2017; Gelaye et al., 2013). The instrument was developed and assessed
using traditional psychometric qualities underpinned by classical test theory (CTT;
Horton & Perry, 2016).
Implications for Social Change in Practice
This project had positive implications for social change as its motive was to
introduce and integrate an evidence-based routine screening for depression, which
facilitated appropriate and timely diagnosis for identified patients. This social change
promoted the well-being and health of the participants as well as their families and
communities at large. There was a need for timely and accurate diagnosis of depression
that would allow patients to have positive health outcomes and live healthy lives, in
which they could contribute to their communities in many positive ways. A healthy
community is a productive community.
Definition of Terms
Definitions for the medical terms used in this project were extracted from multiple
sources.
Asymptomatic: Not showing any symptoms of a disease (“Asymptomatic,” 2018).
Comorbid depression: Depression that develops in the presence of another illness
(“Comorbid Depression,” 2018).
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Depression: A mood disorder that adversely affects how a person feels, thinks,
and handles daily activities and social life (“Depression,” 2018).
Diagnosis: The identification of illness through a screening process and
examination of symptoms (“Diagnosis,” 2018).
Mental disorder: A health condition in the form of a behavioral or psychological
pattern that is a source of the poor ability to function (“Mental Disorder,” 2018).
Plan-do-study-act (PDSA) model: A systematic series of steps used to gain
valuable knowledge and skills for continuous quality improvement (Minnesota
Department of Health, 2018).
Psychometrics: The psychological measurement of knowledge, attitudes, and
personal traits (“Psychometrics,” 2018).
Screening: A method used in a population group to investigate and detect the
presence of an undiagnosed disease such as depression in a population group whose
members are asymptomatic using a methodological approach and relevant tool
(“Screening,” 2018).
Social change: Any process that alters the behavioral patterns and cultural values
of a community over time (“Social Change,” 2018).
Assumptions and Limitations
The question guiding this project was as follows: In adult patients with chronic
diseases at a designated primary care clinic in Maryland, will the implementation of an
evidence-based depression screening tool (PHQ-9) increase the early identification of
depression in patients when compared to the clinic’s baseline depression screening rate
before implementation of the project? The project used the depression screening tool
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(PHQ-9) within the PDSA model to ascertain whether the depression screening tool’s
implementation would improve early identification of depression in patients in this target
population group. This evidence-based practice change project helped to highlight the
benefits of screening for depression at the intervention site. The project identified
participants who needed a professional collaborative continuum of treatment for
depression. The project confirmed that people with chronic diseases are at high risk of
suffering from depression (Centers for Disease Control and Prevention, 2012).
Weaknesses and Limitations of Research Design
The evidence-based practice project was intended to increase the detection and
recognition of depression in patients with chronic diseases at the designated primary care
clinic. In quantitative studies, in which respondents’ answer a series of questions on a
questionnaire, there is usually a danger of response bias and recall bias. The use of
closed-ended questions was dominant in this evidence-based practice change project.
Unfortunately, closed-ended questions do not give the respondents the opportunity to
express their opinions or to explain the reasons for their choice of answers. Closed-ended
questions only allow participants to choose a response. This intervention program also
had some limitations. Due to project time constraints, I was unable to coordinate with the
clinic team to follow up with patients diagnosed with depression to determine whether
the treatment that the patients received was associated with better management of their
chronic conditions. Further, the limited timeframe after project completion did not allow
me to collaborate with the clinic team to monitor patients’ adherence to depression
treatment.
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Summary
Screening provides a way to recognize conditions such as depression in patients
who may be asymptomatic (Thombs et al., 2012). Screening practices are necessary for
realizing better patient outcomes that are possible when patients are diagnosed at a later
phase of the disease. To prevent and mitigate the harmful effects of depression among
people with chronic diseases, healthcare professionals need to take proactive measures to
diagnose the disorder early through screening practices. Those identified to have
depression can then be offered presymptomatic treatment, which reduces health care
costs and increases positive outcomes (DeJean, Giacomini, Vanstone, & Brundisini,
2013). Mental disorders, including depression, cost the nation $56.0 billion annually
(Taylor et al., 2015). This screening project alerted clinicians when patients’ mental state
was likely to affect the treatment of their chronic disease. The clinicians could then
advocate for their patients and provide the necessary psychological support and other
resources for them (Hinz et al., 2016). The significance of this project resides in its
potential to promote accurate and prompt identification and diagnosis of depression in
patients suffering from chronic diseases, which could reduce potential morbidity and
associated costs. If depression is left undiagnosed, it can degenerate into a severe medical
problem that can disrupt families and communities.
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Section 3: Collection and Analysis of Evidence
Review of Scholarly Evidence
The general health of an individual relies heavily on the individual’s
psychological and mental health condition. Over the last few decades, it has increasingly
appeared that there is an association between chronic disease and the development of
depression (Keshavarz et al., 2013). This claim has attracted the attention of many
researchers who have examined and analyzed the few prior research studies that have
been conducted to validate this claim; this project was a result of such an examination
(Keshavarz et al., 2013). It is noteworthy that the review and evaluation of prior research
have focused on scrutinizing studies about the lack of screening for depression in primary
care settings.
Keshavarz et al. (2013) endeavored to conduct a meta-analysis of research carried
out between 1994 and 2012 retrieved from databases such as MEDLINE, PsycINFO,
Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic
Reviews. The purpose of the study was to establish the benefits of screening for
depression in average population groups. The conclusion of the meta-analysis
underscored a dire need to increase early diagnosis of depression and follow-up treatment
for those diagnosed with the disease as well as those most likely to be affected by it.
Though the authors had trouble finding studies revealing evidence of the benefits of
screening, they identified five studies as eligible for their meta-analysis, which made their
study of great importance. It added to and highlighted an aspect of health care that
seemed to be marginalized or less explored. Although the studies that Keshavarz et al.
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identified had few participants, their meta-analysis served to create interest in
investigating the problem further.
Crogan and Evans (2012) responded to the need for research to reveal benefits of
screening for depression among the chronically ill. A two-group prospective quasiexperimental research study was conducted among long-term-care adults who had
multiple chronic diseases. The study was a comparative study of the elderly in long-term
care who underwent routine screening for depression every 6 months and those who were
only receiving routine care in facilities without being screened for depression. A total of
81 residents were recruited for the study. Forty of the residents formed a group whose
members had never been screened for depression, and the rest were from facilities where
they were assessed every 6 months. Participants’ levels of depression were measured
using the Geriatric Depression Scale, which is used to assess depression in older adults
who have mild and moderate cognitive impairment.
Studies revealed that among the group whose members underwent period
screening, the diagnosis of depression decreased from 46% to 29% (Keshavarz et al.,
2013). In a similar group that underwent period screening, the Geriatric Depression Scale
found that there was only a 9.4% decrease in depression among the elderly (Keshavarz et
al., 2013). These results shed light on the efficacy of regular screening for depression as
far as reducing levels of depression is concerned. In cases where there is routine
screening for depression, more cases are identified, which lowers the levels of
unidentified or undiagnosed depression. It confirms the need for regular screening,
particularly among vulnerable population groups likely to suffer from chronic diseases.
Regular screening for depression can result in considerable percentages of people having
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access to treatment. The weakness of the study is that the sample size was small, and the
results might not be generalizable to the rest of the community. Moreover, it was
conducted among residents of facilities that differ from primary care settings. Application
of the findings to the general public should be done with caution.
It is not known which chronic diseases are more associated with the development
of depression. In an effort to address this knowledge gap, Wu (2014) conducted a
descriptive cross-sectional study of 310 individuals suffering from chronic metabolic
syndrome to measure the efficacy of screening for depression. Wu used questionnaires
such as the WHO-5 and PHQ-2 scales. Self-administered questionnaires were used to
collect data on psychological indices and biochemical tests from respondents. The results
from the WHO-5 showed that 5% of the participants had depressive symptoms and 1.0%
were confirmed depression cases (Wu, 2014). The PHQ-2, when administered to the
same participants, revealed that 4.8% had depression (Crogan & Evans, 2012). These
findings confirm not only the validity of the tools used to screen for depression but also
the need for routine screening to identify people suffering from depression so that they
can be placed in appropriate treatment. It is impossible to give patients treatment for
depression if they have not been diagnosed. Untreated depression can have tragic
consequences. The bottom line is that there is a need for sustained screening for
depression in populations whose members are at high risk for depression. This is the
reason that this project is of utmost relevance and importance.
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Concepts
Chronic Pain
Pain that emanates from chronic disease can impair activities of daily living and
interrupt productivity and social life (Banhato, Galil, Campos, Colugnati, & Richter,
2016). Chronic pain can be a source of insomnia, poor nutrition, and poor appetite
(Banhato et al., 2016). These factors can lead to depression in patients. Banhato et al.
(2016) conducted a study among 1,558 participants with multiple chronic conditions at a
center for management of chronic diseases such as diabetes and chronic kidney diseases
in Brazil. The study was an attempt to substantiate the potential correlation between
chronic illness and depression. The study was prompted by an underdiagnosed number of
cases of depression likely to develop among people with chronic health conditions. The
authors used a PHQ-2 tool. The research assistants administered the questionnaire to
participants, and no incentive was given to the participants for their time. Their eligibility
was determined by the WHO definition of chronic disease.
The findings by Banhato et al. (2016) suggested a positive correlation between
suffering from chronic illness and reporting depressive symptoms. It is noteworthy that
this study did not rely on the DSM-IV for diagnosis of depression. Instead, Banhato et al.
used epidemiological screen scales. It is necessary to use the DSM-IV to diagnose
depressive symptoms because this can function as a guideline for determining a treatment
regimen. To diagnose depression without the prospect of treating it is counterproductive.
This current research study indicated that depressive symptoms could remain
undiagnosed and untreated for people with chronic diseases unless a screening program is
established. Efforts to train health care professionals to identify depressive symptoms
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accurately among vulnerable population groups and design appropriate treatment
procedures should precede this.
Chronic Diseases and Comorbid Conditions
To explore the findings regarding the association between chronic diseases and
depression risk several studies have been conducted. One such study was by
Gerontoukou, Michaelidoy, Rekleiti, and Saridi (2015) who conducted an investigative
study among 204 patients living in urban areas. These patients underwent treatment at a
local hospital and were visiting outpatient clinics at that hospital. Gerontoukou et al.
sought to determine their levels of anxiety and depression and to establish a correlation
between the results and the patients’ daily activities. The sample consisted of people who
were suffering from hypertension, diabetes, and hypercholesterolemia. The
instrumentation used in the study was the Greek version of the Zung Self-Rating
Depression Scale for assessment of depressive symptoms due to its reported high
sensitivity, specificity, and repeatability (Gerontoukou et al., 2015). Furthermore, the
Greek version of the Delusions-Symptoms-States Inventory State of Anxiety and
Depression Scale (DSSI/sAD) by Bedford, Foulds, and Sheffield (1976) was used in this
investigative study to assess the level of anxiety and depression of participants. The
results of the study revealed that 35% of the participants were diagnosed with depression
and 56% of them were diagnosed with anxiety (Gerontoukou et al., 2015). These results
indicate a correlation between chronic disease and psychological disorders such as
depression and anxiety, suggesting that chronic illness does trigger these conditions. The
U.S. Preventive Services Task Force (2016) has urged health care professionals to
routinely screen adult populations for depression. Healthcare professionals need to start
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paying attention to individuals suffering from chronic illnesses as far as depression and
other psychological conditions are concerned so that those conditions can be treated
before they progress into potentially tragic developments.
Conceptual Models and Theoretical Frameworks
The evidence-based practice model for this improvement project was the PDSA
model using the PHQ-9 self-reported questionnaire (Institute for Healthcare
Improvement, 2018). There are four stages in the PDSA model: plan, do, study, and act
(Institute for Healthcare Improvement, 2018). The use of the PDSA model encouraged
the drive to integrate screening practices as part of the clinic’s first encounter with
patients with chronic diseases. The planning phase entailed identification of patients with
a major depressive disorder, the type of data collected (mild to severe depressive
symptoms), how data were gathered (PHQ-9), who collected data (the clinic team), when
data were collected (when patients were waiting to be seen by their primary care provider
(PCP), and the location where data were gathered in the assigned examination room
(Institute for Healthcare Improvement, 2018). I initiated this project in collaboration with
the clinicians of the host primary care setting and rest of the primary care team.
Another goal of this evidence-based practice change project was to use this model
as a guide to establish a screening practice for comorbid depression at this intervention
site for patients with chronic diseases to screen and identify depression early. The PDSA
model was chosen for this project because of its versatility. PDSA provides a
straightforward and iterative approach to healthcare delivery practice for quality
improvement. The model provides a framework that can be adopted by any practice
regardless of its resources or size. The PDSA model has been chosen and used
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successfully in many healthcare organizations in which it has served to accelerate change
and improve quality (Institute for Healthcare Improvement, 2018).
The PDSA model is also known as the Deming wheel or Deming cycle. This
concept was first developed by and introduced to Deming by his mentor, Walter
Shewhart, of the famous Bell Laboratories in New York (Deming Institute, 2016).
Approach/Methodology
This quality improvement project was conducted in a suburban primary care
clinic located in the eastern region of Maryland. The population was mostly African
American, Indian, and Caucasian. The clinic did not have any patients who required
bilingual services. Several patients who received care at the clinic received state-run
health care insurance through the state of Maryland. The clinic was open Monday
through Friday and provided primary care services to all age groups, with patients
ranging from the pediatric to the geriatric population. The health care providers at the
clinic included a physician, a nurse practitioner, a physician assistant, a registered nurse,
and three medical assistants.
Project Design/Methods
For this DNP project, the clinic team appointed one of the medical staff members
as the data manager. The data manager was responsible for the review of patients’
medical records, data collection for the project, and data storage. Before the start of the
project, baseline rates of depression screening and diagnosis were obtained by the data
manager from the electronic medical record. The data manager conducted a retroactive
electronic chart review on patients 18 years of age and older who had at least one chronic
disease. These patients needed to have received medical care at the intervention site
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within a year prior to project initiation. The deidentified data after data collection were
provided to me for data analysis.
Before initiating the screening project, I conducted a 30-minute educational
gathering with the appointed clinical staff, who were called the questionnaire
administrators (a physician, a nurse practitioner, a physician assistant, a registered nurse,
and three medical assistants). The session included discussion of the project and its
purpose and the team’s obligations, which included administering and scoring the PHQ-9
(Appendix C). The data manager scanned all completed questionnaires in patients’
respective medical records, and all PHQ scores were documented electronically. Positive
questionnaire scores (PHQ-9 > 10) were given to PCPs, who discussed the results with
participants.
I received authorization from the host clinic’s Institutional Review Board (IRB)
as shown in Appendix B to access and analyze internal, deidentified site records deemed
suitable solely for the doctoral project. I was responsible for conforming with the host
clinic management’s internal policies and requirements as they related to access and use
of deidentified site data for the depression screening program. I applied to the Walden
University IRB for project approval before initiation of the project at the intervention site.
Patients who met the criteria to participate in the project received an informed consent
document with the demographic questionnaire (Appendix D). The demographic
questionnaire included gender, age, race and ethnicity, marital status, education level, and
yearly income. To maintain patient confidentiality, the data manager used the last four
digits of the patients’ medical record numbers rather than patient names for data
collection. Once the project had been initiated by the clinic team, the data manager
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collected all the deidentified data and kept it locked in a secure drawer within a secured
room until the end of the screening project. All completed forms were scanned into the
patients’ electronic health records by the data manager. Moreover, all paper data were
kept in a secured locker within a secured room for a period of 6 to 9 months and were
shredded onsite after the entire project was completed and data analysis was finalized by
me.
Population and Sampling
To meet project inclusion criteria, individuals needed to be patients aged 18 years
or older who received regular medical care at the primary care clinic and who had a
diagnosis of one or more chronic diseases. Additionally, participants must not have
received a previous diagnosis of depression. Convenience sampling served as the method
for selecting healthcare records that met the predetermined criteria.
Depression Toolkit
The PHQ-9 guideline by the New York State Department of Health is a national
guideline that was introduced to the PCPs to determine participants’ severity of
depressive symptoms (AmeriHealth Caritas Louisiana, 2013). According to the New
York State Department of Health (2016), no permission is required to use the PHQ-9
guidelines for health change interventions or programs. With this national guideline, the
PCP could set up a follow-up visit to confirm the diagnosis, discuss treatment options,
or/and refer the patient to a mental health specialist. This guideline was not expected to
substitute for the provider’s clinical judgment; it only represented a source of guidance in
addition to the provider’s clinical judgment.
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Data Collection Process
Instrumentation
Appendix C shows the instrument used for this project, the Patient Health
Questionnaire-9 (PHQ-9). The PHQ-9 is a depression module that includes nine
questions. Scores for the nine questions range from 0 to 27. The questions are answered
by following the DSM-IV criteria from 0 (not at all) to 3 (nearly every day). The total
scores determine the severity of depressive symptoms. The PHQ-9 scores are summed to
indicate the aggregate levels of depression:
•

0-4: None

•

5-9: Mild depression

•

10-14: Moderate depression

•

15-19: Moderately severe depression

•

20-27: Severe depression

Based on the scores, the questionnaire administrators identified positively
screened patients to their PCPs. The target for a positive screen was a PHQ-9 score of >
10. Participants with PHQ-9 scores of 10 or higher were considered positive for clinically
significant depression. A PHQ-9 score of 10 or higher required a follow-up visit to
confirm the diagnosis and discuss the need for treatment with the PCP.
The PHQ-9 is reported to function well when used to screen for depressive
symptoms in patients with chronic diseases (Hinz et al., 2016). Fann et al. (2005) stated
that regression coefficients were applied to analyze collected data. The PHQ-9 has been
shown to have 61% sensitivity and 94% specificity when used in adults (Fann et al.,
2005). The PHQ-9 has been tested in a broad range of populations and deemed to be a
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reliable and valid instrument (American Psychological Association, 2017; Chen et al.,
2016; Spitzer, Williams, & Kroenke, 2014). The PHQ-9 was developed and assessed
using the traditional psychometric qualities underpinned by CTT (DeVellis, 2006).
DeVellis (2006) defined CTT as a method that is broadly used for constructing as well as
evaluating rating scales. The validity of the PHQ-9 instrument has also been established
in research studies, which have included eight primary care settings and seven obstetrical
clinics (Gelaye et al., 2013). The PHQ-9 instrument has been identified as a reliable and
valid tool with remarkable sensitivity and specificity scores (Gelaye et al., 2013).
Additionally, an item-response theory method to evaluate psychometric properties of the
PHQ-9 was used to evaluate its psychometric properties as an instrument for measuring
depression (Gelaye et al., 2013). Their findings established that the instrument is a
reliable means for assessing depression.
Ethics and Human Subjects Protection
Permission was granted by the Walden University IRB (Appendix A) and the
clinic site (Appendix B) to proceed with data collection. The participants that were
involved in the study were all adults, aged 18 and older, who had at least one chronic
disease or more. These patients must have received medical care at the intervention site
within a year period of project initiation. Participants signed a consent form that
explained the objectives of the study, its Risks and benefits, study confidentiality,
participant rights, and information with which to contact the clinic for any further
questions or clarifications. During the data collection process, the questionnaire
administrators respected the participants by observing their right to participate in the
program voluntarily. The depression screening project was explained to the participants
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extensively to reduce any anxiety or negative feelings among them. The reasons for
conducting the program at the clinic were fully explained to them. The questionnaire
administrators applied necessary steps to protect the participants from any breach of
confidentiality during the data collection process by using the last four digits of the
participants’ medical record number. There was need for participants to share their
personal information regarding symptoms of depression, all the deidentified data was
kept locked in a secure drawer within a secured room until the end of the screening
project. After the completion of the data collection process, all completed forms were
scanned into the patient’s electronic health records by the data manager. Moreover, all
paper data was kept in a secured locker within a secured room for a period of 6 to 9
months until the entire project was completed, and data analysis has been finalized by
me. Participants’ confidentiality and anonymity were safeguarded using the health care
delivery protocol. The program was conducted in a manner that posed no risk to the
participants.
Procedure Details for Collecting Data
The data collection process began immediately after I had secured a letter of
cooperation from the designated primary care practice where the depression screening
program was conducted, and from Walden University’s IRB. The depression screening
procedure was carried out in the examination room while the participant was waiting to
be seen by their PCP. The questionnaire administrators informed those that were enrolled
in the program about the purpose of the program to help them understand the significance
of their participation in the program. In the examination room, the questionnaire
administrator administered the PHQ-9 individually to those participants that met the
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criteria for the program. Before the participants started responding to the questionnaire,
they were asked to read the entire consent form and to indicate that they understood it
before signing it as a way of indicating their willingness to participate, voluntarily
without coercion (University of California, Irvine, 2015).
The participants were also encouraged to take note of any concerns about items in
the PHQ-9 and were given feedback on any uncertain areas of the questionnaire for
clarity and understanding. The questionnaire administrators further indicated to the
participants that if they wished to withdraw from participating in the program, they could
do so without fear of reprisals from the clinic staff. The participants were then given a
copy of the PHQ-9 to complete. The participants were instructed to circle their responses
in the form of numerical scores. The questionnaire administrators calculated the score for
each item on the PHQ-9 after the completion of the PHQ-9 form by each participant. The
data manager and the practicum preceptor were involved in the implementation of the
DNP project; they provided needed explanations and clarifications to facilitate
completion of the PHQ-9 questionnaire by the participants. The data manager oversaw all
data, and the practicum preceptor (a physician) monitored and supervised the data
collection process while I coordinated the program.
Data Analysis
After data collection, I was handed de-identified data for data analysis.
Descriptive statistics were conducted to report the demographic characteristics, the
prevalence of the PHQ-9 symptoms and how the depression severity symptoms correlate
with gender. The scores of the PHQ-9 scale were cross-tabulated to report association
among elevated PHQ-9 scores, categorized chronic illnesses and how those factors
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interrelate with gender and the daily functionality of the participants. Certain chronic
medical conditions and participants that scored 10 or higher on the PHQ-9 scale were
examined to see if there is any contribution to gender. This report guided the PCPs to be
more cognizant of the signs of depression when caring for this susceptible group.
A total of 200 participants were asked to participate in the depression screening
program at the primary care clinic. As shown in Appendix D, the demographic
characteristics were age, gender, ethnicity, marital status, level of education, and yearly
income. The age ranges of the sample were 18 and over. Eighty-four (42%) of the
participants were male and116 were female (58%). There were 109 Caucasians, 75
African Americans, 3 Hispanics, and 13 participants categorized as other (Appendix G).
More than 50% of the sample had an education level of high school and below (Appendix
G). Over 50% had an annual income lower than $30,000 (Appendix G). Table G1
provides demographic data regarding the participants who were screened.
Table G2 reports the prevalence of depression severity symptoms by gender. The
results from this analyzed data demonstrated that 42% (n=84) of the participants had
minimal depression, 29% (n=57) of the participants had mild depression, 12% (n=23) had
moderate depression, another 12% (n=24) had moderate-severe depression and 6% (12)
had severe depression. Apparently, the result illustrated that the more chronic diseases the
participants suffered from, the more elevated their PHQ-9 scores and the more severe
their depressive symptoms.
The other data provided by the participants came from their responses to the nine
items in the PHQ-9 that measured the symptoms of depression using score columns for
all nine items on the PHQ-9 scale on Table G3. There is one specific item number on the
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PHQ-9 scale under which most participants who had more than one chronic condition
fall. The item question on the PHQ-9 scale was “Trouble falling/staying asleep/sleeping
too much.” Almost half of the participants screened (n= 98) from a total of 200
participants acknowledged the presence of this symptom in their daily life (Table G3).
Table G4 revealed that 0% of depression screening practices and the absence of
depression screening documentation in the patients’ electronic charts. The post-project
chart review finding as shown in Table G5 revealed a surprisingly high rate of depression
diagnosis (17%) in a small sample as small as 200 patients suffering from chronic
illnesses. Fifteen percent of them were started on antidepressants (Table G5). The DNP
project depression screening program underscores the importance of focusing on mental
illness by integrating screening for depression in primary care settings.
The 200 participants were asked to report how difficult it was to function with the
problems that they were experiencing daily. As shown in Table G6, of the 200
participants, 75 (38%) self-reported “Not difficult at all,” 73 (36%) reported “Somewhat
difficult,” 35 (17%) reported “very difficult” and 17 (9%) “extremely difficult” (Table
G6).
Table G7 showed the association between specific medical conditions and how it
was related to gender. The chronic diseases that were examined included: diabetes,
hypertension, heart disease, kidney disease, COPD/asthma, arthritis, and dyslipidemia.
Other chronic diseases were fibromyalgia, thyroid conditions, multiple sclerosis, cancer,
and psychiatric disorders. Table G7 revealed that many participants were primarily
affected by diabetes (14.5%), dyslipidemia (29.5%), arthritis (18%), and by other chronic
conditions (19%) as mentioned above.
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Many of the participants with one to two chronic conditions scored lower on the
PHQ-9 scale compared to participants that had two or more chronic illnesses. As shown
in Table G8, out of the 84 male participants that were screened for depression, a total of
43 male participants were identified to have more than two chronic medical conditions,
out of those 43 male participants, almost half of the participants self-reported a PHQ-9
higher than 10. Likewise, for the female participants on Table G9. Out of the 116 female
participants that were screened for depression, a total of 72 female participants were
identified to have more than two chronic medical conditions. Out of those 72 female
participants, 37 participants which accounts for more than half of those screened selfreported a PHQ-9 higher than 10 (Table G9).
Project Evaluation Plan
This primary care clinic offered an exceptional privilege to introduce and
integrate an evidence-based quality improvement program to screen out patients who are
at risk of depression. The goal of this program was to implement an evidence-based
depression tool in this primary care setting for all patients with one or more chronic
diseases presenting to the clinic for primary care services. As such, there was a paucity of
research on routine screening for depression among the general adult population. This
project attempted to bridge this gap.
A strategy used in this project toward improving outcomes and quality of health
care for this project was an interdisciplinary teamwork approach. The clinic team
assumed full responsibility for this screening program to administer, score, and interpret
results of the assessment tool, including diagnosis, treatment options, and referrals. The
scope of this screening project was to implement change by initiating an assessment tool
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at the primary care clinic to identify depression early in patients who had chronic
diseases. The intention was to establish a depression screening procedure at the clinic site
using the PDSA model as a framework to initiate quality improvement process (Donnelly
& Kirk, 2015). The PCPs discussed the PHQ-9 scores with all identified patients who had
positive screens (PHQ-9 scores > 10) and then intervened accordingly. The
interdisciplinary team approach involved a partnership with other healthcare
professionals, in this case, mental health specialists, PCPs with other health support
personnel, which formed a community of health care providers to address the mental
health issue. This collaboration promoted depression management programs. Prior
research in randomized clinical trials has revealed that individuals with medical
comorbidities do benefit from screening for depression so that their depression can be
proactively managed using integrated care methods (Coventry, Lovell, Dickens, &
Bower, 2015).
A Cochrane review that involved 79 randomized clinical controlled trials found
that collaborative care is more effective than the usual care for depression (Archer,
Bower, Gilbody, & Lovell, 2012). This project was of benefit to the clinic because it
provided ideas and information for expanding services to include routine depression
screening. It encouraged and developed the interdisciplinary relationships with other
healthcare professionals, such as mental health professionals and chronic disease
specialists. The introduction of screening for depression risks was also used as a quality
measure for the clinic.
The state of Maryland has established the Center for Community Collaboration
through which the state has designed a program known as screening, brief intervention,
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and referral to treatment (SBIRT), which is focused on dissemination of screening, brief
intervention, and referral to treatment for mental disorders that include depression.
However, the screening process remains alarmingly low in the primary care settings in
this state. Thus, the need for projects such as this doctoral project continues to sensitize
the primary care health community to the necessity of screening for mental disorders.
The retention of accurate research data and findings was significant because these
screening data could be used to answer questions about the phenomenon being examined.
They could also be used to answer the project question and to identify areas of further
research and to frame new techniques and approaches to improve health practice.
Summary
Depression is a pervasive mental health disorder across the world. In the United
States, depression accounts for 3.7% of all U.S. disability-adjusted life years and 8.3% of
all U.S. years lived with disability (National Institute of Mental Health, 2015).
Depression is also a leading causative factor for disability. Research has demonstrated
that being diagnosed with chronic illnesses can exacerbate susceptibility to depression
(Unützer & Park, 2012). The Taylor et al. (2015) claim that despite the significant
prevalence of depression in the United States, the detection and subsequent treatment of
comorbid depression in primary care settings remains suboptimal. In the state of
Maryland, 3.0% of all adults are reported to have depressive symptoms each year
(Hedden et al., 2015). That is, about 130,000 people have depressive symptoms each year
and this does not include asymptomatic individuals (Hedden et al., 2015). Apparently,
there is need to initiate proactive measures by implementing routine screening in primary
care settings. As previously reported, current literature indicates that screening improves
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detection, diagnosis, treatment outcomes (Culpepper et al., 2015). This project
endeavored to improve early detection of depression among patients with chronic
diseases in a primary care setting to pave the way for proactive management of
depression using integrated care method.
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Section 4: Findings and Recommendations
Introduction
Depression is a widespread mental health condition across the world (WHO,
2014). It is a leading causative factor for disability (Maryland Department of Health and
Mental Hygiene, 2014). The doctoral project was conducted at a suburban primary care
clinic located in the eastern part of Maryland. The average resident at this location was at
greater risk for suffering from chronic diseases compared to the national average because
of disparities in access to health care services and preventive resources (Maryland
Department of Health and Mental Hygiene, 2014).
According to the Maryland Department of Health and Mental Hygiene (2014), in
the state of Maryland, 3.0% of all adults are reported to have depressive symptoms each
year. That is, about 130,000 people have depressive symptoms each year (Hedden et al.,
2015). This figure does not include asymptomatic individuals. There is a need to initiate
proactive measures by introducing and implementing a depression screening tool at the
designated primary care clinic. Current literature indicates that screening improves
detection, diagnosis, and treatment outcomes (Culpepper et al., 2015). This project
involved an effort to implement early detection of depression among patients with
chronic diseases in a primary care setting to pave the way for proactive management of
depression using integrated health care methods.
Research indicates that there is a 15.6% risk of depression among individuals with
chronic conditions such as asthma, COPD, arthritis, heart disease, and osteoporosis
(Bhattacharya et al., 2014). Maryland is in the second unhealthiest region in the United
States (Maryland Department of Health, n.d.). The adjusted rate of cardiovascular disease
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in Maryland by race is 50.3% for African American men, 45.2% for African American
women, 34.8% for Caucasian women, and 33.5% for Caucasian men (Maryland
Department of Health, n.d.).
The DNP project’s objective was to close the existing gap in the delivery of
primary care services, which has mostly excluded screening for depression at the
practicum site, a primary care clinic located in Maryland. Research shows that two-thirds
of adults seen in primary care remain undiagnosed with depression (Pence, O’Donnell, &
Gaynes, 2013). This project fostered early detection of comorbid depression among
patients with chronic diseases following the implementation of routine screening for
depression at this primary care setting. The project enhanced the roles played by nurses
as leaders to bring forward screening procedures in primary care settings.
The clinic had no routine depression screening practices in place at baseline.
Despite the PCPs’ expertise in managing an array of health conditions at the clinic site,
there was an absence of screening for depressive symptoms. The evidence came from the
clinic’s data, as presented in a baseline report that revealed 0% for depression screening
practices and the absence of depression screening documentation in electronic medical
charts. In light of this information, it was important to identify a reliable tool that would
be used to screen depression among patients with chronic diseases at this primary care
clinic.
Project Summary and Evaluation Report
PCPs are skilled in managing various diseases in their practices. However, their
patients are often not screened for depression; this lack of screening represents a
significant gap in the healthcare delivery system. The results of the program can be used
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not only to encourage other PCPs to adopt integration of routine screening for depression
but also to lobby for more aggressive depression screening policy guidelines and to make
depression a priority preventive practice in the healthcare industry. Because of the
evidence obtained from the depression screening program, other PCPs will be motivated
to become significant advocates for screening and for promoting depression awareness in
their practices and communities. As an evaluator for the depression screening program at
the designated primary care clinic, I supervised and functioned within the context of the
PDSA model and ensured that all cycles of the model were completed to evaluate the
effectiveness of the model (Moore et al., 2014). The program evaluation process involved
synthesizing information about the data collection activities and outcomes of the program
to evaluate the program’s effectiveness and make improvements (Moore et al., 2014).
Furthermore, the evaluation process helped assess the impact of the depression
screening program on the target population group. As an evaluator, the depression
screening program was also assessed to confirm that the program was in alignment with
the purpose for which it was designed. This means that the PDSA model was used to
guide the questionnaire administrators to promote quality improvement (QI) at the
primary care clinic.
The PDSA model diagram (Appendix E) is structured in such a way that it tests a
change that is implemented. It does this through four prescribed steps that guide it and
break down the task of accomplishing the specified steps (Taylor et al., 2015). As shown
in Appendix E, the PDSA model was chosen for that purpose, as it focused on the root of
change and the translation of the intervention (Reed & Card, 2015). The PDSA model is
very appropriate for QI interventions that involve testing changes (Taylor et al., 2015).
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Plan
At this initial stage, the few clinical staff were appointed as “questionnaire
administrators.” I conducted a 30-minute in-service session with the appointed staff to
educate them on depression screening program details, the PHQ-9, the PDSA model, and
the program’s purpose, objectives, and goals. The DNP student reinforced and clarified
what each staff member’s duties were to ensure that all appointed staff were aware of
their roles in relation to the depression screening project.
Do
At this stage, the actual data collection process was conducted. Participants were
screened in the examination room while they were waiting to be seen by their PCP. I
continued to collaborate with the appointed staff and ensured that all activities were
reviewed and monitored. This helped in pinpointing deficiencies so that improvements
could be made when needed. All activities of the entire program were examined and
evaluated. The screening process constituted the “study” part of the model.
Study
During this stage, I reviewed the objectives and purposes of the depression
screening program as well as information gathered from preceding phases to determine
whether the program resulted in the anticipated improvement and whether the entire
project was worth the effort and investment required. I assessed activities of the program
through the data manager. One of the challenges was to determine the best way to
distribute the questionnaires while maintaining the confidentiality of the participants. The
clinic team was advised by me to put the questionnaires in a manila envelope before
giving them out to the participants. Some participants had low literacy skills; they had
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trouble understanding what the questions meant. That issue was addressed by assisting
those participants with reading the questions, as well as simplifying the questions so that
they would not feel uncomfortable due to their inability to read and understand the PHQ9 (Appendix C). Furthermore, the questionnaire administrators came across some
participants who were identified as positive screenings for depression (PHQ-9 scores >
10). Those participants were counselled on depression, and benefits of follow-up care
were discussed with them for proper evaluation.
After data collection, the data manager handed over 200 completed PHQ-9 forms
with deidentified coded data to me after which I evaluated the data. The descriptive
statistical analysis was conducted to determine how effective the PHQ-9 is as a
depression screening tool. All information obtained was used as part of the evaluation
process to address all unanticipated problems.
Act
At this phase of the program, I reviewed the entire program using the PDSA
model to note where improvement was needed. Some recommendations were made to the
clinical staff because the screening process will be an ongoing process as the program
continues following the implementation of the depression screening intervention. The
leaders of the primary care clinic are considering adopting this change into the practice.
The clinic staff plan to screen for depression at least once a year for all returning patients;
all new patients will be screened during their first visit to the clinic. The PDSA model
will continue to improve quality through this project at this intervention site regarding
screening for comorbid depression. Additionally, the staff at the intervention site may
make changes to the program that has been implemented.
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Summary and Evaluation of Findings
PCPs are in optimal positions to screen, identify, diagnose, treat, follow up with
and refer patients to psychotherapy counselling or psychiatrists. The depression screening
intervention was conducted in a designated primary care setting. The PHQ-9 was used to
obtain data from the patient participants regarding depression and provided a means of
scoring patients’ depressive status. Descriptive data analysis was conducted by me to
provide evidence for the findings. Other data that were gathered included participants’
ethnicity, gender, age, level of education, marital status, and income level. The
depression screening intervention was implemented among 200 patients at a designated
primary care clinic in Maryland. After the participants signed the consent form indicating
their willingness to participate in the program, a questionnaire was distributed to them.
After clinic registration, the PHQ-9 (Appendix C) from the New York State Department
of Health (2016) was administered to patients who consented to participate. According to
the depression toolkit (Appendix F), scores of 0 to 4 on the instrument meant that
individuals had minimal depressive symptoms and needed no intervention (see Appendix
F). Questionnaire scores of 5 to 9 were indicative of mild depression; in such cases,
patients needed to be watched closely in case the condition progressed (Appendix F). No
psychotherapy was needed at this stage. Scores of 10 to 14 suggested moderate
depression. A score of 15 to 19 suggested a diagnosis of moderately severe depression
(Appendix F). Scores of 20-27 indicated severe depression (Appendix F).
Discussion of Findings
Depression is recognized as a major health problem that impacts both the mental
and physical health of people living with chronic diseases. This DNP project generated
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more evidence to support the need for regular screening for diagnosis and treatment of
depression among patients suffering from chronic diseases. The PHQ-9, which is a
depression module that includes nine questions, was manually completed by participants,
who circled their responses in the form of numerical scores. The questionnaire
administrators (a physician—practicum preceptor, a nurse practitioner, a physician
assistant, a registered nurse, and three medical assistants) provided needed explanations
and clarifications to facilitate completion of the PHQ-9 questionnaire by the participants.
The questionnaire administrators calculated a score for each item after each participant’s
completion of the PHQ-9 form. The completed forms were scanned into the patient’s
electronic health record, and the PHQ-9 scores were documented electronically by the
data manager. These scores were used as measures to help in understanding depression
outcomes for better monitoring and treatment of depression.
This project functioned to create awareness among PCPs of the importance of
identifying and treating depression in patients suffering from chronic diseases and to
ensure that depressive symptoms are reduced and better managed. The PCPs in the study
were in optimal positions to screen, identify, diagnose, treat, follow up with, and refer
patients to psychotherapy counseling or psychiatrists. No permission is required to use
the PHQ-9 guidelines for health change interventions or programs. Total PHQ-9 scores
determine the severity of depressive symptoms. The PHQ-9 scores were summed to
indicate aggregate levels of depression, as follows: 0-4: none, 5-9: mild depression, 1014: moderate depression, 15-19: moderately severe depression, and 20-27: severe
depression. The depression severity symptoms findings in this study reveal that 42% (n =
84) of the participants had minimal depression, 29% (n = 57) had mild depression, 12%
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(n = 23) had moderate depression, another 12% (n = 24) had moderate-severe depression,
and 6% (n = 12) had severe depression (Table G2). A very interesting finding was that
the postproject chart review revealed a surprisingly high rate of depression diagnosis at
17% for such a small sample size of 200 patients suffering from chronic illnesses (Table
G5).
Based on the PHQ-9 scores, patients considered positive for clinically significant
depression with a PHQ-9 score > 10 were identified by the questionnaire administrators. I
provided the PCPs with a depression toolkit that contained guidelines for using the PHQ9 from the New York State Department of Health (2016). These guidelines described
various courses of action depending on patients’ PHQ-9 scores. The PHQ-9 scores were
translated to actual diagnoses; for example, PHQ-9 scores of 10-14 required that the PCP
propose treatment and counseling to the patient, whereas PHQ-9 scores of 20-27
represented severe depression and required the PCP to pursue immediate initiation of
treatment and expedite referral of the patient to a mental health facility. The patients were
referred to their PCPs, who discussed the results and counseled them on depression and
the benefits of follow-up care for proper evaluation. The PCPs then set up follow-up
visits to confirm the diagnoses, discuss treatment options, or/and refer the patients to
mental health specialists. During the follow-up visit, the PCPs discussed the PHQ-9
scores with the patients who had positive screens (PHQ-9 scores > 10) and then advised
them accordingly. The PCPs undertook an interdisciplinary team approach that involved
partnerships with other healthcare professionals, including mental health specialists, to
address the mental health issues, which promoted depression management programs for
patients.
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The scope of this DNP project encompassed implementing change through the
initiation of an assessment tool at the primary care clinic that helped with the early
identification of depression in patients suffering from chronic diseases. This assessment
did not serve as a substitute for the patients’ initial clinical judgment; it only acted to
provide additional information to inform the initial clinical judgment. I pursued this study
in an effort to guide the PCPs to be more cognizant of the signs of depression when
caring for patients with chronic diseases because the clinic initially had no routine
depression screening practices in place. Routine screening would increase rates of
diagnosis and treatment of depression while contributing to patients’ self-management
practices.
The study findings reveal that routine screening for depression among patients
suffering from chronic depression is important. The depression screening program will
help PCPs realize the need for routine screening will enhance their knowledge and
understanding of mental health. In addition, their healthcare practices will improve, and
they will be in a position to mitigate the deleterious effects of patient depression. In
realizing the need for routine screening, PCPs can become leaders in fighting morbidity
and mortality associated with depression through early detection and treatment.
Implications
The unanticipated outcomes of the depression screening findings, as shown in
Table G5, included a surprisingly high rate of definite depression diagnosis (17%). A
total of 34 participants were newly diagnosed with depression (Table G5). A total of 30
participants (15%) were started on antidepressants (Table G5), while four participants
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(2%) refused treatment and 60 participants (30%) scored 10 or greater on the PHQ-9
questionnaire and were identified as positive screens. It was surprising to see a definite
depression diagnosis percentage of 17%, which was higher than the state figure of 15%.
About 6% of depression diagnosis was indicated by research conducted by Bhattacharya
et al. (2014). In other words, the findings of this DNP project may indicate that the
percentage of depression is higher in the state than initially believed.
The high percentage of depression among the 200 participants in this DNP project
suggested that there is a need to integrate screening for depression in primary care
settings. The aim is to be able to identify patients with depression who need access to
treatment to mitigate morbidity and enhance patient outcomes. Patients with moderately
severe depressive symptoms and severe depressive symptoms need to be monitored to
ensure that their condition remains under control. The successful detection of depression
in the designated primary care setting is significantly important due to the complex
interaction between mental and physical health. Primary care institutions, particularly
those serving less advantaged communities, can serve as gateway institutions for access
to collaborative care for patients.
The outcomes of the depression screening intervention show that it is possible to
petition the healthcare industry to make screening for depression a standard of care.
Doing so will make it easier for people suffering from depression to be screened so that
depressive symptoms can be detected early, which is imperative for the development of
healthy and productive communities. PCPs can help to reduce mental health disparities in
the target populations and increase awareness of depression in the community. The
project has positive implications for social change, in that the primary aim was to
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introduce and integrate evidence-based routine screening for depression, which was
introduced and facilitated appropriately in the diagnosis of identified patients. The project
supports the recommendation that timely and accurate diagnosis of depression is initiated
in primary care institutions to have positive health outcomes for patients with depression.
Project Strengths and Limitations
A limitation of the depression screening program is that the questionnaire
administrators only used one screening instrument, the PHQ-9, for data collection. It may
have been more beneficial to use more than one instrument to compare its efficacy
toward detecting depressive symptoms in this and other target population.
Another limitation of the project is that our sample consisted of only 200
voluntary participants recruted from only one primary care setting as a captive sample.
As such, it is not known how well the findings could be generalized to the general
population at the state or national levels. Therefore, a generalization of the results should
be conducted with caution. Since depression can affect memory, it is possible that some
participants were not able to recall some of their symptoms. However, the PHQ-9
questions used to collect information were structured in a way that helped participants
remember how they felt to provide relevant information for the project (Moore et al.,
2014). Furthermore, our timeline for completing the project only permitted the appointed
clinic team to implement interventions at one institution. Nevertheless, our findings have
contributed to the argument that there is a need for integration of screening for depression
in primary care settings. The project findings are also consistent with the literature on
screening for depression in primary care (Robinson et al., 2008). By addressing these
issues, the health care delivery system could improve the quality of patient-centered care

42
through early identification and diagnosis of depression and could improve outcomes
(Robinson et al., 2008). The instrument that was used in the project has a high sensitivity
and specificity and has been validated and frequently used in studies for depression
screening.
On Tables G8 and G9, the tool identified patients with multiple chronic diseases
to have severe depression. The more chronic diseases they had, the more they were likely
to have severe depression (Walker et al., 2014). There was no statistical analysis done,
only descriptive statistics. Also, there was no control group used for comparison. Hence,
it was difficult to tell if there existed a statistically significant relationship. However, the
following calculation was done - the mean for the prevalence of PHQ-9 symptoms among
the patients (μ = (Σ Xi ) /n) was 19 for males and 32.5 for females. This means that the
prevalence of PHQ-9 for depression was almost double for females compared to their
male counterparts. The mode was 38 for males and 60 for females. Standard Deviation
(SD) = 13.51).
Contribution of the Doctoral Project Team
I was the overseer for the implemented project at the designated primary care
clinic. I worked with the questionnaire administrators of the primary care practice. The
questionnaire administrators were: one physician (practicum preceptor), one nurse
practitioner, a registered nurse (data manager) and three medical assistants). The
appointed clinical staff known as the questionnaire administrators identified patients who
were suffering from chronic diseases, met the project criteria and were willing to
participate in the study. The questionnaire administrators administered both the PHQ-9
form and the demographic questionnaire (Appendix D) to the participants. The

43
questionnaire administrators also collected information about the gender, race or
ethnicity, marital status, and race of the participants. When the participants had
completed the questionnaires, they were collected and given to the project data manager
for coding and storage. The project team assessed and evaluated the need for screening
for depression before approving it. The data manager provided the necessary guidance
and facilitation for designing and implementing the program at the designated practice,
under the auspice of me and the practicum preceptor.
The implemented program should be extended beyond its current location; there
is a need to reach out to other PCPs, the psychiatric community, and the mental health
community to adopt the depression screening program. It will create an opportunity to
work as an integrated, interdisciplinary team to encourage routine depression screening,
diagnosis, and treatment, particularly among population groups suffering from chronic
diseases. This way, it is possible to lobby insurance carriers to cover screening services
and ensuing treatment modules.
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Section 5: Analysis of Self
As a professional and doctorate nursing student leading the depression screening
program at the practicum site, I served as the content expert for the program. I introduced
an existing instrument, the PHQ-9 tool, to the clinic staff to screen and detect for
depression symptoms. The tool guided the questionnaire administrators to collect data
from patients suffering from chronic diseases. By providing scholarly and relevant
information about the tool to the staff, I was able to coordinate and facilitate the
implementation of the depression screening program at a designated primary care clinic
located in Maryland.
Summary and Conclusions
The collaborative effort to disseminate the findings of my DNP project will target
the potential adopters of the findings at the practicum site where the program was
conducted. As a team, the clinic staff and I will target other primary care settings,
integrated delivery systems, healthcare insurance companies, and independent practice
associations. We will endeavor to disseminate these findings as a team and report
evidence from the program to audiences such as healthcare professionals across the
board, policymakers, and community leaders as well as psychiatry professionals using
professional publications, the media, and seminars. As a team, we will also target PCP
consortia.
It has been reported by the U.S. Preventive Services Task Force (2016) that
depression is among the leading causes of disability among people aged 15 and above. As
such, its multifaceted deleterious effects touch families, industries, and society. By
considering the persistent pain associated with chronic health conditions, it becomes
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necessary for nursing leaders to conduct a project that assesses the prevalence of
depression among individuals suffering from chronic diseases. My implemented program
indicated that there was a significant rate of depression among the population group
studied. Based on the program findings, the clinic team and I believe that it is necessary
for primary care practices to integrate depression screening into the primary care setting.
It is essential to work closely with clinicians at the primary care clinics to disseminate the
findings of the program and thus increase awareness of the need to screen for depression
in people with chronic illnesses.
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Appendix A: Walden University IRB Approval
Project approval was granted by the Walden University Institutional Review
Board on September 12, 2017. The approval number to proceed with the DNP Quality
Improvement Evaluation is 0568309.
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Appendix C: PHQ-9

Patient
Name

Date

1. Over the last 2 weeks, how often have you been bothered by any of the
following problems? Read each item carefully and circle your response.

a. Little interest or pleasure in doing things
b. Feeling down, depressed, or hopeless
c. Trouble falling asleep, staying asleep, or
sleeping too much
d. Feeling tired or having little energy
e. Poor appetite or overeating
f. Feeling bad about yourself, feeling that
you are a failure, or feeling that you have
let yourself or your family down
g. Trouble concentrating on things such as
reading the newspaper or watching
television
h. Moving or speaking so slowly that other
people could have noticed. Or being so
fidgety or restless that you have been
moving around a lot more than usual
i. Thinking that you would be better off
dead or that you want to hurt yourself in
some way
Totals

Not
at all

Several
days

0

1

More
than
half the
days
2

Nearly
every
day
3
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2. If you checked off any problem on this questionnaire so far, how difficult have
these problems made it for you to do your work, take care of things at home, or
get along with other people?
Not Difficult at All

Somewhat Difficult

Very Difficult

0

1

2

Extremely
Difficult
3

Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and
colleagues, with an educational grant from Pfizer Inc. No permission required to
reproduce, translate, display, or distribute.
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Appendix D: Demographic and Background Characteristics Questionnaire
Gender:

a. Male

b. Female

Age:

a. 18-30

b. 31-40

e. 60-70

f. 71+

Race and Ethnicity:

a. Non-Hispanic/ Caucasian
c. Hispanic/Latino

Marital Status:

Level of Education:

c. 41-50

d. 51-59

b. African American

d. Other

a. Single

b. Married

c. Separated

d. Widowed

e. Divorced

f. living together

a. Less than a high school diploma

b. High school diploma

c. Some college or Associate’s degree

d. Bachelor’s degree

e. Postgraduate degree
Yearly Income:

a. Under $10,000

b. $10,000 - $19,999 c. $20,000 - $29,999

c. $30,000 - $39,999 d. $40,000 - $49,999 e. $50,000 - $74,999
f. $75,000 - $99,999 g. over $100,000
Medical Conditions: a. Diabetes
d. Kidney disease
g. Arthritis

b. Blood Pressure

c. High Cholesterol

e. Heart disease

f. COPD/Asthma

h. Other

(Circle all that apply)
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Appendix E: PDSA Model Diagram

Note. This diagram was used to guide depression screening intervention and to interpret
data findings to the clinic team. The PDSA diagram is in Open Access and can be
accessed at any time. No permission is required to reproduce, translate, or display
provided that appropriate citation is used (Perry, Bell, Fitzpatrick & Sampson, 2014). The
model was also used as a framework for the project’s evaluation process.
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Appendix F: Depression Toolkit Contents
Guidelines for using PHQ-9 from New York State Department of Health (2016)
PHQ-9 Depression Severity Score

Proposed Treatment Actions

0-4 Minimal

No treatment recommended

5-9 Mild depression

Watch the patient closely just in case
it progresses. No recommended
treatment at this stage.

10-14 Moderate depression

Propose treatment and counseling

15-19 Moderately severe depression

Patient needs active treatmentpharmacotherapy and psychotherapy

20-27 Severe depression

Requiring immediate initiation of
treatment; expedite referral to a
mental health specialist.

(New York State Department of Health, 2016)
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Appendix G: Cross-Tabulations of Descriptive Statistics Data
Table G1
Demographic Characteristics of Screened Participants
Variables
No of participants screened
Gender
Male
84
Female
116
Age
Male
18-30
14
31-40
16
41-50
16
51-59
19
60-70
15
71+
4
Ethnicity
Male
Caucasian
52 (26%)
African American
27 (14%)
Hispanic/Latino
2 (1%)
Other
3 (2%)

Percentage
42%
58%
Female
16
24
23
24
18
11
Female
57 (29%)
48 (24%)
1 (< 1%)
10 (5%)
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Table G2
Demographic Characteristics of Screened Participants
Marital status
Single
Married
Separated
Widowed
Divorced
Living together
Level of education
< High school diploma
High school diploma
Associate’s degree
Bachelor’s degree
Postgraduate degree
Yearly income
Under $10,000
$10,000 to $19,999
$20,000 to $29,999
$30,000 to $39,999
$40,000 to $49,999
$50,000 to $74,999
$75,000 to $99,999
Over $100,000

Male
36
31
1
5
7
4
Male
8
45
22
7
2
Male
13
16
12
6
13
11
10
3

Female
44
42
9
6
11
4
Female
12
52
37
8
3
Female
27
25
19
14
13
10
3
5

Prevalence of Depression Severity Symptoms by Gender
Table G3
Range of PHQ-9 Scores

0-4 Minimal
5-9 Mild depression
10-14 Moderate depression
15-19 Moderately severe
20-27 Severe depression

N (%)
42%
29%
12%
12%
6%

Males
40
23
7
12
2

Females
44
34
16
12
10
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Table G4
Prevalence of PHQ-9 Symptoms by Gender
PHQ-9 item

N

Males Females

1. Little interest/pleasure in doing things

63

23

40

2. Feeling down/depressed/hopeless

48

14

34

3. Trouble falling/staying asleep/sleeping too much 98

38

60

4. Feeling tired/little energy

79

33

46

5. Poor appetite/overeating

62

18

44

6. Feeling bad about self/that you are a failure/

32

12

20

43

17

26

32

9

23

6

4

2

have let yourself down/let your family down
7. Trouble concentrating (reading newspaper
or watching television)
8. Moving or speaking so slowly that other
people notice/Or opposite: fidgety/restless/
moving around a lot more than usual
9. Thoughts that you would be better off dead/
or of hurting yourself in some way
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Table G5
Preproject Chart Review (N = 200)
Number of patients screened
before intervention

Number of patients
screened after intervention

0

200

Table G6
Postproject Chart Review Findings: Total Participants Screened (N = 200)
No. of Patients
Positive PHQ-9
Diagnosed with
Started on
screened
(score > 10)
depression
antidepressants
200
60 (30%)
34 (17%)
30 (15%)
Note. Four participants refused depression treatment—religion and personal reasons.

Table G7
Association Between PHQ-9 Scores and Daily Functionality
Not difficult at all

Male

Female

Total
number of
participants
(N)

Percentage
(%)

Somewhat difficult

32

43

75

38%

Very difficult

34

39

73

36%

Extremely difficult

14

21

35

17%

Not difficult at all

4

13

17

9%

Note. The question was “How difficult have these problems made it for you to do
your work, take care of things at home, or get along with other people?”
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Table G8
Association Between Specific Chronic Medical Conditions and Gender (N=200)
Medical conditions
Diabetes
Hypertension
Dyslipidemia
Kidney disease
Heart disease
COPD/asthma
Arthritis
Other chronic conditions (fibromyalgia, thyroid
conditions, multiple sclerosis, cancer, and psychiatric
disorders)

Male %
5%
15%
4%
< 1%
2%
2%
5%
9%

Female %
10%
15%
4%
1%
2%
5%
13%
10%

Table G9
Association Between Elevated PHQ-9 Scores and Characterized Chronic Illnesses in
Males
Category for
comorbid chronic
diseases

Male

PHQ-9
score
below 10

PHQ-9 score
between 1014

PHQ-9 score
between 1519

PHQ-9 score
between 2027

1 chronic
condition

41

40

1

0

0

1-3 chronic
conditions

17

7

3

7

0

Over 3 chronic
conditions

26

17

2

5

2
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Table G10
Association Between Elevated PHQ-9 Scores and Characterized Chronic Illnesses in
Females
Category for
comorbid
chronic
diseases
1 chronic
condition

Female

PHQ-9
score
below 10

PHQ-9 score
between 1014

PHQ-9 score
between 1519

PHQ-9 score
between 2027

44

41

3

0

0

30

19

5

4

2

Over 3 chronic 42
conditions

16

9

11

6

1-3 chronic
conditions

68
Appendix H: Scholarly Product for Dissemination
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